Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

C Chouaid1,2

  • 1Service de Pneumologie, CHI Créteil, Créteil, France.

Revue Des Maladies Respiratoires Actualites
|December 14, 2020
PubMed
Summary
This summary is machine-generated.

COVID-19 significantly impacts lung cancer patients, with factors like age and smoking increasing mortality risk. Immunotherapy may reduce this risk, while careful treatment management is crucial.

Area of Science:

  • Oncology
  • Infectious Diseases
  • Public Health
Keywords:
ChemotherapyCovidHealth systemLung cancerRadiotherapySurgery

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimisation and validation of line-of-therapy advancement algorithms in advanced/metastatic non-small-cell lung cancer: an I-O Optimise study.

ESMO real world data and digital oncology·2026
Same author

Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC.

ESMO open·2026
Same author

Prediction of survival and outcomes with depth of response at 6 months in metastatic non-small-cell lung cancer patients treated with chemotherapy and immunotherapy combination: SPORE trial.

ESMO open·2026
Same author

Efficacy of first-line treatments for advanced pulmonary sarcomatoid carcinomas: a real-world analysis.

ESMO open·2025
Same author

Durvalumab after sequential chemoradiotherapy in unresectable stage III non-small-cell lung cancer-final analysis from the phase II PACIFIC-6 trial.

ESMO open·2025
Same author

[Influence of smoking on the efficacy of immunotherapy in advanced lung cancers].

Revue des maladies respiratoires·2025
Same journal

Revue des maladies respiratoires actualites·2022
Same journal

Revue des maladies respiratoires actualites·2022
Same journal

Revue des maladies respiratoires actualites·2022
Same journal

Revue des maladies respiratoires actualites·2022
Same journal

[Highlights in Respiratory Medicine in 2021].

Revue des maladies respiratoires actualites·2022
Same journal

Revue des maladies respiratoires actualites·2022
See all related articles